Abstract
The antiproliferative effects of the fluoropyrimidine derivatives, 5-fluorouracil (5-FU), 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur), UFT, 1-hexylcarbamoyl-5-fluorouracil (HCFU), and 5′-deoxy-5-fluorouracil (5′DFUR), were investigated in a 4 day subrenal capsule assay. The antiproliferative effects against two human tumor xenografts established in athymic mice were examined after treatment with three different doses of each anticancer agent, and the adequate dose of each anticancer agent in this experimental system was estimated as: 473 mg/kg for Tegafur, 433 mg/kg for UFT, 50 mg/kg for HCFU and 185 mg/kg for 5′DFUR, respectively. A comparative study of the antiproliferative effects of fluoropyrimidine derivatives was carried out against 7 xenografts. According to our criteria of positive tumor response, the effective rates were: 1 of 7 (14.3 per cent) by 5-FU, 2 of 7 (28.6 per cent) by Tegafur, 2 of 7 (28.6 per cent) by UFT, 1 of 6 (16.7 per cent) by HCFU, and 1 of 4 (25.0 per cent) by 5′DFUR, respectively. Although no statistical differences were demonstrated between the agents, the utility of a chemosensitivity test before clinical use was suggested.
References
Fujii S, Ikenaka K, Fukushima M, Shirasaka T. Effect of uracil and its derivatives on antitumor activity of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil. Gann 1978; 69: 763–772.
Mabuchi K, Kaneko H, Kobari T. Inhibition rate of thymidylate synthetase and concentration of FdUMP and dUMP in mouse tumor after administration of 5-fluorouracil derivatives. Yakuri To Chiryo (Jpn Pharmacol & Ther) 1986; 14: 153–160. (in Japanese)
Bollag W, Hartmann HR. Tumor inhibitory effects of a new fluorouracil derivative: 5′-deoxy-5-fluorouridine. Eur J Cancer 1980; 16: 427–432.
Fujita F, Fujita M, Taguchi T. Effects of 5′-deoxy-5-fluoropyrimidine on human gastrointestinal and breast cancers xenografted to nude mice. Gan To Kagakuryoho (Jpn J Cancer Chemother) 1984; 11: 1635–1643. (in Japanese)
Bogden AE, Cobb WR, Lepage DJ, Haskell PM, Gulkin TA, Ward A, Kelton DE, Esber HJ. Chemotherapy responsiveness of human tumors as first transplant generation xenografts in the normal mice: six-day subrenal capsule assay. Cancer 1981; 48: 10–230.
Levi FA, Blum JP, Lemaigre G, Bourt C, Reinberg A, Mathe GA. A four-day subrenal capsule assay for testing the effectiveness of anticancer drugs against human tumors. Cancer Res 1984; 44: 2660–2667.
Nishiyama M, Niimi K, Takagami S, Hirabayashi N, Yamaguchi M, Saeki T, Yoshinaka K, Wang DC, Niimoto M, Hattori T. Combined effects of UFT with other anticancer agents usingin vivo chemosensitivity tests. Jpn J Surg (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nishiyama, M., Takagami, S., Kirihara, Y. et al. The antiproliferative effects of fluoropyrimidine derivatives against human tumor xenografts in a subrenal capsule assay. The Japanese Journal of Surgery 18, 725–728 (1988). https://doi.org/10.1007/BF02471537
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02471537